Integra Lifesciences Holdings Corp
2018 Q3 - 2025 Q4 (30 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 444 | 0.0% | 35,778 | 12/31/2025 |
| 2025 Q3 | 11/13/2025 | 588 | 0.0% | 41,050 | 9/30/2025 |
| 2025 Q2 | 8/13/2025 | 504 | 0.0% | 41,050 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 903 | 0.0% | 41,050 | 3/31/2025 |
| 2024 Q4 | 2/13/2025 | 947 | 0.0% | 41,749 | 12/31/2024 |
| 2024 Q3 | 11/13/2024 | 720 | 0.0% | 39,638 | 9/30/2024 |
| 2024 Q2 | 8/13/2024 | 504 | 0.0% | 17,304 | 6/30/2024 |
| 2024 Q1 | 5/14/2024 | 1,325 | 0.0% | 37,367 | 3/31/2024 |
| 2023 Q4 | 4/22/2024 | 1,670 | 0.0% | 38,352 | 12/31/2023 |
| 2023 Q3 | 5/9/2024 | 1,550 | 0.0% | 40,598 | 9/30/2023 |
| 2023 Q2 | 4/29/2024 | 1,756 | 0.0% | 42,705 | 6/30/2023 |
| 2023 Q1 | 5/9/2024 | 2,558 | 0.0% | 44,549 | 3/31/2023 |
| 2022 Q4 | 5/10/2024 | 2,565 | 0.0% | 45,742 | 12/31/2022 |
| 2022 Q3 | 5/10/2024 | 1,976 | 0.0% | 46,650 | 9/30/2022 |
| 2022 Q2 | 5/10/2024 | 2,513 | 0.0% | 46,513 | 6/30/2022 |
| 2022 Q1 | 5/10/2024 | 3,026 | 0.0% | 47,096 | 3/31/2022 |
| 2021 Q4 | 5/17/2024 | 2,365 | 0.0% | 35,300 | 12/31/2021 |
| 2021 Q3 | 5/17/2024 | 2,393 | 0.0% | 34,944 | 9/30/2021 |
| 2021 Q2 | 5/17/2024 | 2,422 | 0.0% | 35,487 | 6/30/2021 |
| 2021 Q1 | 5/17/2024 | 2,529 | 0.0% | 36,607 | 3/31/2021 |
| 2020 Q4 | 5/24/2024 | 2,515 | 0.0% | 38,737 | 12/31/2020 |
| 2020 Q3 | 5/24/2024 | 1,914 | 0.0% | 40,528 | 9/30/2020 |
| 2020 Q2 | 5/24/2024 | 1,965 | 0.0% | 41,819 | 6/30/2020 |
| 2020 Q1 | 7/12/2023 | 1,827 | 0.0% | 40,909 | 3/31/2020 |
| 2019 Q4 | 7/12/2023 | 2,384 | 0.0% | 40,909 | 12/31/2019 |
| 2019 Q3 | 7/12/2023 | 2,480 | 0.0% | 41,291 | 9/30/2019 |
| 2019 Q2 | 7/12/2023 | 2,347 | 0.0% | 42,032 | 6/30/2019 |
| 2019 Q1 | 7/13/2023 | 2,403 | 0.0% | 43,122 | 3/31/2019 |
| 2018 Q4 | 7/13/2023 | 1,944 | 0.0% | 43,109 | 12/31/2018 |
| 2018 Q3 | 7/13/2023 | 2,850 | 0.0% | 43,260 | 9/30/2018 |